Nerelimomab, CAS 162774-06-3

Product Description: Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Schlag G, et al. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 1994 Jul;2(1):10-8; discussion 19-22. /[2]Cohen J, et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996 Sep;24(9):1431-40.

CAS Number: 162774-06-3

Molecular Weight: N/A

Research Area: Infection

Solubility: 10 mM in DMSO

Target: TNF Receptor

• Artikelnummer: MEXHY-P99753-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99753-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated